Amphastar Pharmaceuticals Total Assets 2012-2024 | AMPH

Amphastar Pharmaceuticals total assets from 2012 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
Amphastar Pharmaceuticals Annual Total Assets
(Millions of US $)
2023 $1,513
2022 $742
2021 $672
2020 $631
2019 $587
2018 $514
2017 $451
2016 $428
2015 $390
2014 $389
2013 $339
2012 $317
2011 $0
2009 $300
Amphastar Pharmaceuticals Quarterly Total Assets
(Millions of US $)
2024-06-30 $1,492
2024-03-31 $1,574
2023-12-31 $1,513
2023-09-30 $1,545
2023-06-30 $1,378
2023-03-31 $774
2022-12-31 $742
2022-09-30 $727
2022-06-30 $724
2022-03-31 $716
2021-12-31 $672
2021-09-30 $652
2021-06-30 $666
2021-03-31 $646
2020-12-31 $631
2020-09-30 $614
2020-06-30 $600
2020-03-31 $573
2019-12-31 $587
2019-09-30 $586
2019-06-30 $601
2019-03-31 $545
2018-12-31 $514
2018-09-30 $481
2018-06-30 $452
2018-03-31 $450
2017-12-31 $451
2017-09-30 $438
2017-06-30 $444
2017-03-31 $436
2016-12-31 $428
2016-09-30 $429
2016-06-30 $409
2016-03-31 $395
2015-12-31 $390
2015-09-30 $395
2015-06-30 $399
2015-03-31 $397
2014-12-31 $389
2014-09-30 $401
2014-06-30 $397
2014-03-31 $345
2013-12-31 $339
2013-09-30 $0
2013-06-30 $0
2013-03-31 $0
2012-12-31 $317
2012-09-30 $0
2012-06-30 $0
2012-03-31 $0
2011-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $2.469B $0.644B
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.902B 7.10
Dr Reddy's Laboratories (RDY) India $12.399B 18.57
BridgeBio Pharma (BBIO) United States $4.791B 0.00
Bausch Health Cos (BHC) Canada $3.597B 2.61
Supernus Pharmaceuticals (SUPN) United States $1.872B 377.44
Taysha Gene Therapies (TSHA) United States $0.314B 51.00
Personalis (PSNL) United States $0.270B 0.00
Assembly Biosciences (ASMB) United States $0.107B 0.00
Acasti Pharma (GRCE) Canada $0.031B 0.00
Sol-Gel Technologies (SLGL) Israel $0.014B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00